HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cecil Fandiño Selected Research

Infections

1/2021[Cost-effectiveness of ceftazidime/avibactam versus colistin + meropenem for treatment of carbapenemic-resistant enterobacteria infections in Chile].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cecil Fandiño Research Topics

Disease

1Infections
01/2021
1Cicatrix (Scar)
12/2003
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
12/2003
1Tuberculosis (Tuberculoses)
03/2002

Drug/Important Bio-Agent (IBA)

2Tuberculin (PPD)IBA
12/2003 - 03/2002
1Meropenem (Merrem)FDA LinkGeneric
01/2021
1Colistin (Coly-Mycin)FDA Link
01/2021
1ceftazidime drug combination avibactamIBA
01/2021
1Complement System Proteins (Complement)IBA
12/2003